Central Laboratories Featured Articles

  1. How To Avoid Hazards And Map A Safer, Smarter Path For AI, Part 1 7/15/2025

    Even with a clear destination with real rewards, the AI journey is full of hidden potholes, unexpected detours, and costly wrong turns. Tanisha Patel and Vincent Puglia explore several considerations when integrating AI in clinical research.

  2. Clinical Trials Get A Council For AI Oversight 7/14/2025

    AI in clinical trials is moving fast — but without clear standards for ethics, transparency, or oversight. Advarra's new Council for Responsible Use of AI in Clinical Trials aims to change that. Founding members Sanofi, Recursion, and Velocity Clinical Research are stepping up to define what “responsible” really looks like.

  3. How Is RIM Software Transforming Regulatory Compliance? 6/20/2025

    Regulatory information management (RIM) software tools streamline global regulatory processes on a single cloud-based platform throughout the entire product life cycle.

  4. Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU 6/4/2025

    Discover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative. 

  5. In The Age Of AI, Data Is Still King 5/29/2025

    While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.

  6. What's The Risk Of Letting Researchers Use LLMs? 5/21/2025

    Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.

  7. How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 5/19/2025

    Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.

  8. How Recursion Is Industrializing Clinical Trials With AI 5/12/2025

    Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.

  9. Caregiver Distress: The Hidden Burden Of Dementia With Lewy Bodies — And Why Measuring It Matters 5/7/2025

    Taking care of a loved one can be challenging. Cognition Therapeutic experts contend that caregivers’ distress levels must be evaluated to better understand the impact of dementia with Lewy bodies (DLB) on patients, families, and society.

  10. Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis 5/5/2025

    Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient.